XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.3
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 01, 2023
Apr. 01, 2023
Aug. 31, 2023
Feb. 28, 2023
Jul. 31, 2022
Apr. 30, 2022
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Apr. 04, 2022
Apr. 30, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Cash consideration   $ 16,792,037                      
Options to acquire shares           144,191            
Weighted exercise price           $ 10.71              
Warrants to purchase shares           4,424              
Exercise price           $ 7.32              
Expiration date           Apr. 22, 2031              
Payments to contingent consideration   $ 893,000                      
Cash     $ 693,000                    
Cash consideration         $ 10,000,000.0                
Number of shares         486,145                
Earnout payment     $ 693,000                    
Number of shares issued, value               $ 1,033,761          
Stock granted and issued                   107,797      
Restricted stock award, gross                   $ 4,287,777      
Share-based compensation             $ 857,526   $ 683,202 2,582,163 $ 1,971,537    
Unrecognized share-based compensation expense             $ 3,980,624     $ 3,980,624      
Unrecognized share-based compensation expense period for recognition                   1 year      
Cash Closing Consideration [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Payments to acquire assets $ 15,250,000                        
Purchase Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of common stock in equity offering, shares         94,798                
Payments to acquire assets         $ 7,600,000                
Cash         $ 1,600,000                
Issuance of common stock for purchase of assets         291,686                
Net proceeds         $ 1,950,000                
Common Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of common stock in equity offering, shares               26,143          
Warrants to purchase shares           12,301              
Exercise price           $ 12.05              
Expiration date           Aug. 10, 2030              
Number of shares issued, value               $ 26          
Common Stock [Member] | Sales Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of common stock in equity offering, shares                   26,143      
Number of shares issued, value                   $ 1,066,000      
Net proceeds                   $ 1,034,000      
Precision Healing [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Payment in cash           $ 600,000              
Share price           $ 27.13             $ 27.13
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Percentage of commissions payable to sales agent       3.00%                  
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member] | Maximum [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Sale of stock, consideration received on transaction       $ 75,000,000                  
Accredited Investors [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Accredited investors shares           165,738              
Nonaccredited Investors [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Share price                       $ 30.75  
Precision Healing Inc [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Cash consideration           $ 125,966              
Payments to contingent consideration           $ 10,000,000.0              
Restated 2014 Omnibus Long Term Incentive Plan [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares available for issuance             1,412,535     1,412,535      
Restated 2014 Omnibus Long Term Incentive Plan [Member] | Directors Officers Employees [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Issuance of common stock in equity offering, shares                   587,465